Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Glaucoma
Paediatric cataracts
AMD
Spectacles filter
Glaucoma research


Survey

Do you believe public perception about LASIK needs improving?

83% Yes
17% No

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.

September 15, 2010


First post-surgical scarring therapeutic for glaucoma patients moves to Phase II study
A Phase 2a clinical study has been initiated for Promedior’s anti-fibrotic therapeutic, PRM-151, to evaluate its efficacy, safety and tolerability. This drug is aimed at the prevention of post-surgical scarring in glaucoma patients. More...
The Paediatric Cataract Initiative is now accepting applicants for its inaugural single small research grant
US$75,000 will be awarded to a qualified individual, institution or organization investigating the causes of paediatric cataract and/or improved treatment tools and protocols. More...
Promising study results presented in Age Related Macular Disease at ASRS
A team of retina specialists at the Doheny Eye Institute, University of Southern California, led by Srinivas Sadda, MD, conducting a study using have found that 76% of eyes in patients with AMD had peripheral abnormalities. More...
Product Profile
Carl Zeiss Meditec
IOLMaster® 500 - With automatic and non-contact measurement of the patient's eye, the new IOLMaster 500 offers the fastest and easiest way of calculating the right IOL for each patient.

Read more...

Spectacles filter to help migraine sufferers
A new product, MigraLens, designed to filter red and blue light and help migraine sufferers is now available. More...

Glaucoma Research Foundation hosts Catalyst meeting
Scientists from around the world gathered at a recent Glaucoma Research Foundation Catalyst meeting to discuss new research ideas that could lead to a cure for glaucoma. More...

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom